C-reactive protein as an early marker of immune-related adverse events

ConclusionCRP elevation can predict the onset of irAEs in patients treated with ICIs in the absence of infectious disease.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research